Cabaletta Bio (CABA) Enterprise Value (2018 - 2025)

Cabaletta Bio's Enterprise Value history runs 8 years deep, the most recent figure standing at -$184.2 million for Q4 2025.

• On a quarterly basis, Enterprise Value fell 12.35% year-over-year to -$184.2 million in Q4 2025; TTM through Dec 2025 was -$184.2 million, a 12.35% decrease from a year earlier, with the FY2025 full-year figure at -$184.2 million, down 12.35% from the prior year.
• Enterprise Value slipped to -$184.2 million in Q4 2025 per CABA's latest filing, from -$159.9 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$93.8 million in Q1 2023 and bottomed at -$272.4 million in Q1 2024.
• The 5-year median for Enterprise Value is -$145.9 million (2025), against an average of -$161.5 million.
• Across the five-year window, Enterprise Value tumbled 190.26% in 2024 and jumped 51.6% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$122.2 million in 2021, then grew by 12.83% to -$106.5 million in 2022, then plunged by 126.42% to -$241.2 million in 2023, then jumped by 32.04% to -$164.0 million in 2024, then fell by 12.35% to -$184.2 million in 2025.
• Per Business Quant, the three latest CABA Enterprise Value figures stand at -$184.2 million (Q4 2025), -$159.9 million (Q3 2025), and -$243.8 million (Q2 2025).